Australia's largest stock trading and investment forum Australia's #1 stock forum

AN1

Click for more information

0.00%

0.8¢ anagenics limited

Capital raising, page-22

First 22 Last

Share
Profile

Follow
kirsty78

568 Posts.

31/10/16

12:33

Post #: 20249003
Share

Originally posted by Pharmargeddon ↑

And Ill refrain from being pessimistic until it is clear what is the nature of the capital raising.
There was 2 mill in the bank last quarter, we have a record sales in the last quarter indicating business is growing, there is a 1.2 mil contribution from options, with noticeable abstainers.
If more capital is needed it is probably for a midkine related clinical trial.
If that is the case then venture capital may be coming into Lyramid or Kinera which would require some pretty serious negotiation.
All conjecture but quite a few things dont add up as yet.
Could be wrong but I think one of the reasons for the low option uptake was the descent to .017 last march/april. A lot of smaller optionholders may have elected to flag them away and go in at a much lower price on head shares.

Expand

I agree with a cornerstone investor/s as you don't suspend on negotiating price and quant. No fat in the SP for the oppie holders hence no take up. LMIG somehow involved concerned that they have disbanded which indicates a SPP is on the way....would explain the suspension also as the co would need a prospectus!

CDY Price at posting: 3.3¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

C29

C29 Metals wins Kazakhstani uranium drill run green tick, Kazatomprom talks mature

QHL

Aerospace smallcap Quickstep Holdings jumps nearly 100% after 40cps takeover offer

PFE

Pantera begins drilling of maiden test well at Smackover

First 22 Last

Add AN1 (ASX) to my watchlist